AnaptysBio Inc (NASDAQ:ANAB)

17.97
Delayed Data
As of Sep 29
 -0.03 / -0.17%
Today’s Change
16.51
Today|||52-Week Range
32.44
-42.01%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for AnaptysBio Inc have a median target of 28.00, with a high estimate of 45.00 and a low estimate of 20.00. The median estimate represents a +55.82% increase from the last price of 17.97.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in AnaptysBio Inc. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.79
Sales
$2.8M
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.11%
 
 
 
 
 
 
Growthannually -50.42%
 
 
 
 
 
 

Sales

Growthquarterly -18.49%
 
 
 
 
 
 
Growthannually 7.87%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.